Aaron Dumas

Title: Aaron Dumas: Innovator in FGFR Inhibitors

Introduction

Aaron Dumas is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. His work focuses on innovative methods of making and using these compounds, which have potential therapeutic applications.

Latest Patents

Dumas holds a patent for "FGFR inhibitors and methods of making and using the same." This patent is directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide. The patent also covers its salts, cocrystals, and variants thereof. He has 1 patent to his name.

Career Highlights

Dumas is currently associated with Relay Therapeutics, Inc., where he continues to push the boundaries of drug discovery and development. His expertise in FGFR inhibitors positions him as a key player in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include André Lescarbeau and Jethro Beamish-Cook. Their collaborative efforts contribute to the innovative environment at Relay Therapeutics.

Conclusion

Aaron Dumas is a prominent inventor whose work on FGFR inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the pharmaceutical landscape.